Jérome Hadjadj

11PUBLICATIONS
130CO-AUTHORS
Building information modelling and managementMolecular targetsCancer geneticsMedical virologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2026
Exploring glucocorticoid dose-response patterns in VEXAS syndrome: a pilot retrospective study.

|Sep 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.

Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro

|May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Jerome Hadjadj, Yann Nguyen, Dalila Mouloudj

|Dec 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.

Benjamin de Valence, Marion Delaune, Yann Nguyen

|May 27, 2023
Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases.

E Oliosi, A Flahault, C Charre

|Jan 13, 2023
Successful outcome under multiple therapy in two cases of anti-MDA5 dermatomyositis with severe cardiomyopathy and interstitial lung disease.

Anaïs Roeser, Jérôme Hadjadj, Lola Prat

Pageof 2

Frequent Collaborators

6 joint publications

Benjamin Terrier

3 joint publications

Frédéric Rieux-Laucat

3 joint publications

Arsène Mekinian

3 joint publications

Yann Nguyen